Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 6,311 INR
Change Today 0.00 / 0.00%
Volume 0.0
SKB On Other Exchanges
Symbol
Exchange
Natl India
OTC US
As of 7:05 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

glaxosmithkline consumer hea (SKB) Snapshot

Open
6,406
Previous Close
6,377
Day High
6,478
Day Low
6,275
52 Week High
04/15/15 - 6,575
52 Week Low
05/13/14 - 4,105
Market Cap
265.4B
Average Volume 10 Days
20.7K
EPS TTM
132.80
Shares Outstanding
42.1M
EX-Date
07/28/14
P/E TM
47.5x
Dividend
45.00
Dividend Yield
0.71%
Current Stock Chart for GLAXOSMITHKLINE CONSUMER HEA (SKB)

Related News

No related news articles were found.

glaxosmithkline consumer hea (SKB) Related Businessweek News

No Related Businessweek News Found

glaxosmithkline consumer hea (SKB) Details

GlaxoSmithKline Consumer Healthcare Limited operates in the health food drinks industry in India. It manufactures and markets health food drinks, nutritional supplements, biscuits, and choco-malt drinks under the Horlicks, Boost, Maltova, and Viva brand names. The company also offers over-the-counter medicine, including Crocin, a pain and body ache relieving drug; Crocin Pain Relief, a pain relief medicine; Crocin Cold and Flu, which provides relief from cold; and Crocin paediatric medicines for infants, toddlers, and older kids up to 12 years. In addition, it provides Eno, an antacid for acidity, gastric discomfort, and heat burn; and Iodex for head, neck, back joint, and muscular pains, as well as Iodex creams and gels; and oral care products under the Sensodyne brand name. The company exports its products to Pakistan, Myanmar, Sri Lanka, Bangladesh, the Middle East, Nepal, Kenya, and Malaysia. GlaxoSmithKline Consumer Healthcare Limited was incorporated in 1958 and is headquartered in Gurgaon, India.

3,502 Employees
Last Reported Date: 07/11/14
Founded in 1958

glaxosmithkline consumer hea (SKB) Top Compensated Officers

Managing Director, Senior Vice President of I...
Total Annual Compensation: 97.4M
Director of Finance, Wholetime Director, Memb...
Total Annual Compensation: 36.7M
Director of Operations, Wholetime Director an...
Total Annual Compensation: 36.4M
Compensation as of Fiscal Year 2014.

glaxosmithkline consumer hea (SKB) Key Developments

Glaxosmithkline Consumer Healthcare Limited Reports Unaudited Standalone Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

GlaxoSmithKline Consumer Healthcare Limited reported unaudited standalone earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported net profit of INR 964.1 million or INR 22.92 per basic and diluted share compared to INR 797.50 million or INR 18.96 per basic and diluted share a year ago. Net sales/income from operations were INR 9,751.7 million compared to INR 8,391.1 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 927.6 million compared to INR 772.0 million a year ago. Profit from ordinary activities before tax was INR 1,473.6 million compared to INR 1,213.1 million a year ago. For the year, the company reported net profit of INR 3,868.2 million or INR 91.97 per basic and diluted share compared to INR 5,030.5 million or INR 119.60 per basic and diluted share a year ago. Net sales/income from operations was INR 29,713.8 million compared to INR 36,039.3 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 4,290.7 million compared to INR 5,970.9 million a year ago. Profit from ordinary activities before tax was INR 5909.1 million compared to INR 7,551.2 million a year ago.

GlaxoSmithKline Consumer Healthcare Limited, Board Meeting, Feb 03, 2015

GlaxoSmithKline Consumer Healthcare Limited, Board Meeting, Feb 03, 2015. Agenda: To consider quarterly results.

GlaxoSmithKline Consumer Healthcare Limited to Report Q3, 2015 Results on Feb 03, 2015

GlaxoSmithKline Consumer Healthcare Limited announced that they will report Q3, 2015 results on Feb 03, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKB:IN 6,311.30 INR 0.00

SKB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arena Pharmaceuticals Inc $4.64 USD -0.02
DC Brands International Inc $0.0001 USD -0.0001
Perrigo Co PLC $198.98 USD -0.02
VIVUS Inc $2.42 USD 0.00
View Industry Companies
 

Industry Analysis

SKB

Industry Average

Valuation SKB Industry Range
Price/Earnings 47.7x
Price/Sales 6.3x
Price/Book 12.7x
Price/Cash Flow 43.4x
TEV/Sales 5.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE CONSUMER HEA, please visit www.gsk-ch.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.